Acesion Pharma
Denmark - CopenhagenPharmaceutical
Focus: Acesion Pharma is a small molecule cardiovascular-focused pharmaceutical company headquartered in Copenhagen, Denmark. The company is in early clinical development with two Phase 2 programs targeting atrial fibrillation.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Acesion Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Acesion Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AP31969
Atrial FibrillationClinical Trials (3)
NCT07267949Clinical Randomised Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
Phase 2Help build intelligence for Acesion Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.